Company: SCLXW
Filing Date: 2025-07-23
Form Type: 424B3
Source: 0001193125-25-163077
Chunk: 227

Company: Scilex Holding Co
Filing Date: 2025-07-23
Form: 424B3
Chunk 227
---
 the “”):

(i) on or before September 30, 2025, (A) Purchaser shall pay Oramed
$13,000,000.00 in cash by wire transfer of immediately available funds to an account or accounts designated by Oramed (the “”), and (B) Oramed shall execute and deliver to Purchaser, one or more assignment
forms in the form attached hereto as (the “”), for the assignment of Subject Warrants exercisable for 3,130,000 Warrant Shares (the “” and such Subject
Warrants, the “”), and solely upon receipt of the First Warrant Payment by Oramed, the closing of the Initial Warrant Assignment pursuant to this clause (i) shall be deemed effective (the
“”); and

(ii) on or before December 31, 2025, (A) Purchaser shall
pay Oramed $14,000,000.00 in cash by wire transfer of immediately available funds to an account or accounts designated by Oramed (the “”, and together with the First Warrant Payment, the “” and each a “”) and (B) Oramed shall execute and deliver to Purchaser, one or more Assignment Forms for the assignment of Subject Warrants exercisable for 3,370,000 Warrant Shares (the
“” and such Subject Warrants, the “”), and solely upon receipt of the Final Warrant Payment by Oramed, the closing of the Final Warrant Assignment pursuant to this
clause (ii) shall be deemed effective (the “” and together with the First Warrant Purchase Closing, the “” and each a “”). The Warrant Purchase Closings together with the Option Closings are referred to herein as the “” and each, a “”).

(c) . If any Option Closing Payment is not delivered in full on or prior to the date of the applicable
Option Closing Payment Date, interest on the unpaid portion of any such amount shall commence accruing on the date of the applicable unpaid Option Closing Payment Date, shall accrue at a rate of twelve percent (12.0%) per annum and shall be computed
based on a 360-day year and twelve 30-day months; , , that (i) any such penalty interest arising from any payment failure shall only
become due and payable if Oramed’s Termination Right with respect to and arising from such payment failure lapses unexercised pursuant